Italy
# |
Name |
EBT Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
39.03%
|
Dec. 31, 2023 | USD 2.00 | 0.87% |
|
Italy |
|
2 |
23.58%
|
Dec. 31, 2023 | USD 61.94 | 0.17% |
|
Italy |
|
3 |
23.02%
|
Dec. 31, 2023 | USD 54.52 | 1.77% |
|
Italy |
|
4 |
17.52%
|
Dec. 31, 2023 | USD 106.08 | -0.85% |
|
Italy |
|
5 |
17.46%
|
Dec. 31, 2023 | USD 22.41 | 2.19% |
|
Italy |
|
6 |
1.96%
|
Dec. 31, 2023 | USD 9.87 | -1.00% |
|
Italy |
|
7 |
-26.72%
|
Dec. 31, 2023 | USD 19.11 | -0.17% |
|
Italy |
|
8 |
-178.87%
|
Dec. 31, 2023 | USD 10.99 | 1.17% |
|
Italy |
The Healthcare company in Italy with the highest EBT Margin is Arterra Bioscience (Milan Stock Exchange: ARBS.MI) at 39.03%.
The Healthcare company in Italy with the lowest EBT Margin is Newron Pharmaceuticals S.p.A. (XETRA: NP5.DE) at -178.87%.
The top 10 Healthcare companies in Italy by EBT Margin are Arterra Bioscience, Recordati Industria Chimica e Farmaceutica S.p.A., Pharmanutra S.p.A., DiaSorin S.p.A., Stevanato Group S.p.A., GPI S.p.A., Philogen S.p.A. and Newron Pharmaceuticals S.p.A..
The bottom 10 Healthcare companies in Italy by EBT Margin are Newron Pharmaceuticals S.p.A., Philogen S.p.A., GPI S.p.A., Stevanato Group S.p.A., DiaSorin S.p.A., Pharmanutra S.p.A., Recordati Industria Chimica e Farmaceutica S.p.A. and Arterra Bioscience.